Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MSL3 |
| Upstream (Parents) |
|---|
| (<<) SALL1 → MSL3 |
| (<<) ESR1 → MSL3 |
| (<<) AR → MSL3 |
| (<<) KLF5 → MSL3 |
| (<<) TCF3 → MSL3 |
| (<<) NR4A1 → MSL3 |
| (<<) ZGPAT → MSL3 |
| (<<) NFIC → MSL3 |
| (<<) NFAT5 → MSL3 |
| (<<) RXRA → MSL3 |
| Downstream (Children) |
|---|
| MSL3 → ASCL1 (>>) |
| MSL3 → RUNX1 (>>) |
| MSL3 → HOXD1 (>>) |
| MSL3 → ZIC3 (>>) |
| MSL3 → NR2E3 (>>) |
| MSL3 → ZFP36L1 (>>) |
| MSL3 → SCAND2 (>>) |
| MSL3 → KDM5B (>>) |
| MSL3 → NR0B1 (>>) |
| MSL3 → ZNF154 (>>) |
| MSL3 → POU3F4 (>>) |
| MSL3 → ZNF41 (>>) |
| MSL3 → FOXI1 (>>) |
| MSL3 → ZSCAN2 (>>) |
| MSL3 → EVX1 (>>) |
| MSL3 → SMAD9 (>>) |
| MSL3 → TP73 (>>) |
| MSL3 → NFYA (>>) |
| MSL3 → ZNF202 (>>) |
| MSL3 → TAF4B (>>) |
| MSL3 → E2F4 (>>) |
